ZCTFFZero Candida Technologies Inc.

About Zero Candida Technologies Inc. (ZCTFF)

Zero Candida Technologies Inc. (ZCTFF) is a N/A company headquartered in Vancouver, BC, Canada whose shares trade over-the-counter on the OTCQB tier.

Zero Candida is a FemTech company developing innovative solutions to address unmet needs in women's health. Their tampon-like device uses artificial intelligence and therapeutic blue light at a precise wavelength and intensity to effectively treat Candida fungus, with a proven 99.999% success rate in POC. Vulvo-Vaginal Candidiasis (VVC) affects approximately 75% of women worldwide, and recurrent cases (four or more episodes per year) are increasingly resistant to existing drug treatments, as the root cause remains poorly understood and inadequately addressed. ZCT is following a de novo regulatory pathway and is finalizing the device for human use in preparation for an upcoming clinical trial, after successfully completing a safety trial in large animals (sheep). The company has secured funding and partnerships with leading hospitals in Europe and Israel, while expanding its global patent portfolio with applications filed in the United States, Brazil, and Europe, and is fully patented in South Africa. With the VVC treatment market projected to exceed USD $2B in the next five years, ZCT is combining hybrid medicine and technology-based diagnostics to improve access to underserved populations and bring gynecology into the 21st century.

Products and services

The Company is developing a novel and personalized diagnostic and therapeutic vaginal technology to allow women to live life with zero limitations and achieve their full potential by alleviating the stigma of hidden treatable diseases and vaginal disorders that lower quality of life and functioning. Without side effects or chemicals, the device will leverage AI to transmit real-time data to the attending physician for personalized and remote care. B2B Model: Zero Candida plans to showcase its product at global exhibitions and collaborate with gynecologists to promote its hybrid diagnostic technology for Candida infections, aiming to increase diagnoses, treatments, and revenue for gynecologists. B2C Model: The company will partner with medical organizations, leveraging existing businesses and generating royalties through franchise and distribution agreements.

ZCTFF key facts

Ticker symbol

ZCTFF

Market tier

OTCQB

Headquarters

Vancouver, BC, Canada

Country of incorporation

CA

Year of incorporation

2021

Employees

5

Estimated market cap

$6.92M (as of May 14, 2025)

Shares outstanding

19,627,856

Reporting standard

International Reporting: TSX Venture Exchange

Audit status

Audited

Fiscal year end

12/31

Latest filing

Quarterly Report (Sep 30, 2024)

Zero Candida Technologies Inc. leadership

• Eli Ben Haroosh — CEO
• Sophya Galper Komet — CFO
• Asher Holzer — CTO, President
• Victoria Gamble — Corporate Development Officer

Explore more: OTCQB stocks · OTC stocks starting with Z